Efficacy and Safety of Immersive Virtual Reality for Post-stroke Cognitive Impairment
EVRPSC
A Single-blind Randomized Controlled Trial to Evaluate Efficacy and Safety of Immersive Virtual Reality for Post-stroke Cognitive Impairment
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
This is a single-blind randomized controlled trial to evaluate the efficacy and safety of immersive virtual reality for post-stroke cognitive impairment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Dec 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2024
CompletedFirst Posted
Study publicly available on registry
November 26, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedNovember 26, 2024
November 1, 2024
11 months
November 21, 2024
November 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Mental State Examination Scale (MMSE)
Global cognitive function assessment. Easy to use and one of the most used scales to screen person with cognitive impairment in the world. The minimum and maximum values range from 0 to 30. Higher score means better cognition level.
1. finished in 3 days before training. 2. finished 3 days after 30-days training
Montreal Cognitive Assessment (MoCA)
one of the most used scales to assess cognition and screen person with cognitive impairment in the world. The minimum and maximum values range from 0 to 30. Higher score means better cognition level.
1. finished in 3 days before training. 2. finished 3 days after 30-days training
Brain functional activation (fNIRS)
Brain functional activation of each patient during the cognitive task (Stroop task, 1-back task and verbal fluency test) will be evaluated using functional near-infrared spectroscopy (fNIRS).
1. finished in 3 days before training. 2. finished 3 days after 30-days training
Study Arms (2)
VR group (virtual reality cognitive training group)
EXPERIMENTALImmersive VR cognitive training with suitable training intensity.
OT group (occupational therapy group)
ACTIVE COMPARATORConventional cognitive training (occupational therapy) with suitable training intensity.
Interventions
Pathfinding training with immersive VR.
Only receive conventional cognitive training group
Eligibility Criteria
You may qualify if:
- Diagnosis of stroke by neuroimaging (CT or MRI) assessment
- years old
- Be able to follow instructions to complete the test
- Can tolerate the rehabilitation training of this experiment
- First stroke
- Patients who signed informed consent
You may not qualify if:
- The test could not be tolerated due to organic disease
- There is a serious mental illness resulting in inability to cooperate with or tolerate this test
- is participating in another clinical trial involving an investigational drug or physical therapy
- Patients who have not signed informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dingqun Bailead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dingqun Bai
First Affiliated Hospital of Chongqing Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of rehabilitation Medicine
Study Record Dates
First Submitted
November 21, 2024
First Posted
November 26, 2024
Study Start
December 1, 2024
Primary Completion
November 1, 2025
Study Completion
December 1, 2025
Last Updated
November 26, 2024
Record last verified: 2024-11